[{"edinetCode":"E05712","endDate":"2016\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":183.0,"averageTemporaryStaff":4.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13823519.0,"sharesOwendPercent":0.1212,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2017\/3\/29","stockCode":2160,"accountingYear":"第16期（自　2016年１月１日　至　2016年12月31日）","accountingYearStart":"2016\/1\/1","accountingYearEnd":"2016\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":275.0,"averageTemporaryStaff":4.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":13728078.0,"sharesOwendPercent":0.1018,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2018\/3\/30","stockCode":2160,"accountingYear":"第17期（自　2017年１月１日　至　2017年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":346.0,"averageTemporaryStaff":3.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1688935.0,"sharesOwendPercent":0.1218,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"asr","submitDate":"2019\/3\/29","stockCode":2160,"accountingYear":"第18期（自　2018年１月１日　至　2018年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/15","stockCode":2160,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":1650845.0,"sharesOwendPercent":0.1188,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q2r","submitDate":"2019\/8\/14","stockCode":2160,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":null,"currentAssets":null,"fixedAsset":null,"tangibleFixedAssets":null,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":null,"currentLiabilities":null,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":null,"capitalSurplus":null,"accumulatedEarnings":null,"treasuryStock":null,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":null,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/14","stockCode":2160,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":458.0,"averageTemporaryStaff":10.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":7514673.0,"sharesOwendPercent":0.1733,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":20607389000.0,"currentAssets":10241232000.0,"fixedAsset":null,"tangibleFixedAssets":2399936000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":7511555000.0,"currentLiabilities":3216173000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8212985000.0,"capitalSurplus":4273412000.0,"accumulatedEarnings":-1764904000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":1050911000.0,"grossProfit":null,"sgaExpenses":4334435000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":610.23,"roe":null,"cashFlowFromOperatingActivities":788587000.0,"depreciationAndCashflowFromOperatingActivities":236753000.0,"cashFlowFromInvestingActivities":-153122000.0,"cashFlowFromFinancialActivities":2218118000.0,"changesInCashAndCashEquivalents":2804598000.0,"列1":"asr","submitDate":"2020\/3\/31","stockCode":2160,"accountingYear":"第19期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":21282512000.0,"currentAssets":10989928000.0,"fixedAsset":null,"tangibleFixedAssets":2395902000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":8165763000.0,"currentLiabilities":3903049000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8216705000.0,"capitalSurplus":4214200000.0,"accumulatedEarnings":-1632552000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":377012000.0,"grossProfit":null,"sgaExpenses":1122503000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":551137000.0,"depreciationAndCashflowFromOperatingActivities":71854000.0,"cashFlowFromInvestingActivities":-74057000.0,"cashFlowFromFinancialActivities":347982000.0,"changesInCashAndCashEquivalents":757522000.0,"列1":"q1r","submitDate":"2020\/5\/15","stockCode":2160,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":5419974.0,"sharesOwendPercent":0.1249,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":21265336000.0,"currentAssets":11142523000.0,"fixedAsset":null,"tangibleFixedAssets":2360843000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":8001150000.0,"currentLiabilities":3755392000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8216705000.0,"capitalSurplus":4097788000.0,"accumulatedEarnings":-1520424000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":741067000.0,"grossProfit":null,"sgaExpenses":2212614000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":808203000.0,"depreciationAndCashflowFromOperatingActivities":155389000.0,"cashFlowFromInvestingActivities":-186332000.0,"cashFlowFromFinancialActivities":122388000.0,"changesInCashAndCashEquivalents":647950000.0,"列1":"q2r","submitDate":"2020\/8\/14","stockCode":2160,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":21888137000.0,"currentAssets":11825294000.0,"fixedAsset":null,"tangibleFixedAssets":2382653000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":8243681000.0,"currentLiabilities":4156817000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8265650000.0,"capitalSurplus":3899798000.0,"accumulatedEarnings":-1297931000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":1125039000.0,"grossProfit":null,"sgaExpenses":3495866000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1249673000.0,"depreciationAndCashflowFromOperatingActivities":210936000.0,"cashFlowFromInvestingActivities":-196025000.0,"cashFlowFromFinancialActivities":-92618000.0,"changesInCashAndCashEquivalents":895211000.0,"列1":"q3r","submitDate":"2020\/11\/13","stockCode":2160,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":539.0,"averageTemporaryStaff":5.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":6905065.0,"sharesOwendPercent":0.1587,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":23219257000.0,"currentAssets":13024686000.0,"fixedAsset":null,"tangibleFixedAssets":2425021000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":10450153000.0,"currentLiabilities":6603478000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":8268472000.0,"capitalSurplus":3591101000.0,"accumulatedEarnings":-608019000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":null,"costOfSales":1545943000.0,"grossProfit":null,"sgaExpenses":5180715000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":62.43,"roe":null,"cashFlowFromOperatingActivities":1377519000.0,"depreciationAndCashflowFromOperatingActivities":329611000.0,"cashFlowFromInvestingActivities":570205000.0,"cashFlowFromFinancialActivities":801115000.0,"changesInCashAndCashEquivalents":2648303000.0,"列1":"asr","submitDate":"2021\/3\/31","stockCode":2160,"accountingYear":"第20期（自　2020年１月１日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":27117456000.0,"currentAssets":16213236000.0,"fixedAsset":null,"tangibleFixedAssets":2579812000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":9849897000.0,"currentLiabilities":3074506000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":10218178000.0,"capitalSurplus":5561226000.0,"accumulatedEarnings":-327362000.0,"treasuryStock":-472000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":455717000.0,"grossProfit":null,"sgaExpenses":2194415000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1507840000.0,"depreciationAndCashflowFromOperatingActivities":86535000.0,"cashFlowFromInvestingActivities":-71785000.0,"cashFlowFromFinancialActivities":1093492000.0,"changesInCashAndCashEquivalents":3038281000.0,"列1":"q1r","submitDate":"2021\/5\/17","stockCode":2160,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9622258.0,"sharesOwendPercent":0.2027,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":28990008000.0,"currentAssets":17622947000.0,"fixedAsset":null,"tangibleFixedAssets":2654372000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":9909549000.0,"currentLiabilities":2282980000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":10884332000.0,"capitalSurplus":6227991000.0,"accumulatedEarnings":182675000.0,"treasuryStock":-567000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":785692000.0,"grossProfit":null,"sgaExpenses":3677925000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1100855000.0,"depreciationAndCashflowFromOperatingActivities":181290000.0,"cashFlowFromInvestingActivities":-1006877000.0,"cashFlowFromFinancialActivities":2906178000.0,"changesInCashAndCashEquivalents":3498457000.0,"列1":"q2r","submitDate":"2021\/8\/13","stockCode":2160,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0},{"edinetCode":"E05712","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":null,"cashAndCashEquivalents":null,"assets":29788899000.0,"currentAssets":18318681000.0,"fixedAsset":null,"tangibleFixedAssets":2726200000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":null,"liabilities":10359818000.0,"currentLiabilities":2441549000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":null,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":null,"capitalStock":null,"capital":10884332000.0,"capitalSurplus":6224649000.0,"accumulatedEarnings":535639000.0,"treasuryStock":-567000.0,"valuationAndConversionAdjustments":null,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":1209298000.0,"grossProfit":null,"sgaExpenses":5503838000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":null,"nonOperatingIncome":null,"nonOperatingExpenses":null,"interestExpense":null,"ordinaryProfit":null,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":null,"incomeTaxes":null,"netIncome":null,"netIncomeAttributableToOwnersOfTheParentCompany":null,"comprehensiveIncome":null,"eps":null,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":755120000.0,"depreciationAndCashflowFromOperatingActivities":274619000.0,"cashFlowFromInvestingActivities":-884057000.0,"cashFlowFromFinancialActivities":3176682000.0,"changesInCashAndCashEquivalents":3622810000.0,"列1":"q3r","submitDate":"2021\/11\/15","stockCode":2160,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"IFRS","consolidatedAccounting":true,"edinetCode2":"E05712","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":7525,"settlementDate":"2022\/12\/31","submitterName":"株式会社ジーエヌアイグループ","submitterNameEnglish":"GNI  Group Ltd.","submitterNameKana":"カブシキガイシャジーエヌアイグループ","location":"中央区日本橋本町二丁目２番２号","industory":"医薬品","corporateNumber":4010000000000.0}]